These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8562173)
21. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
22. Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer. Jones DV; Winn RJ; Brown BW; Levy LB; Pugh RP; Wade JL; Gross HM; Pendergrass KB; Levin B; Abbruzzese JL Cancer; 1995 Nov; 76(10):1709-14. PubMed ID: 8625038 [TBL] [Abstract][Full Text] [Related]
23. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial. Abad A; Garcia P; Gravalos C; Tusquets I; Font A; Perez G; Cortés-Funes H; Fabregat X; Barnadas A; Rosell R Cancer; 1995 Mar; 75(6):1238-44. PubMed ID: 7882275 [TBL] [Abstract][Full Text] [Related]
24. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer. Gamelin E; Delva R; Jacob J; Merrouche Y; Raoul JL; Pezet D; Dorval E; Piot G; Morel A; Boisdron-Celle M J Clin Oncol; 2008 May; 26(13):2099-105. PubMed ID: 18445839 [TBL] [Abstract][Full Text] [Related]
25. Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. Saini A; Norman AR; Cunningham D; Chau I; Hill M; Tait D; Hickish T; Iveson T; Lofts F; Jodrell D; Ross PJ; Oates J Br J Cancer; 2003 Jun; 88(12):1859-65. PubMed ID: 12799627 [TBL] [Abstract][Full Text] [Related]
26. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?]. Carnaghi C; Zucali P; Garassino I Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298 [TBL] [Abstract][Full Text] [Related]
27. A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer. Haas NB; Schilder RJ; Nash S; Weiner LM; Catalano RC; Ozols RF; O'Dwyer PJ Invest New Drugs; 1995; 13(3):229-33. PubMed ID: 8729951 [TBL] [Abstract][Full Text] [Related]
28. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076 [TBL] [Abstract][Full Text] [Related]
29. Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer. Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Chen PM Hepatogastroenterology; 2000; 47(36):1599-603. PubMed ID: 11149011 [TBL] [Abstract][Full Text] [Related]
30. 5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial. Sdrobolini A; Contu A; Massidda B; Gasperoni S; Recchia F; Iannelli A; Tomao S; Romiti A; Raffaele M; Ortu S; Campisi C; Gebbia V; Olmeo N; Ionta MT; Angiona S; Di Costanzo F Tumori; 2000; 86(3):211-4. PubMed ID: 10939601 [TBL] [Abstract][Full Text] [Related]
31. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U; Wilke H; Seeber S J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323 [TBL] [Abstract][Full Text] [Related]
32. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. Lévi FA; Zidani R; Vannetzel JM; Perpoint B; Focan C; Faggiuolo R; Chollet P; Garufi C; Itzhaki M; Dogliotti L J Natl Cancer Inst; 1994 Nov; 86(21):1608-17. PubMed ID: 7932825 [TBL] [Abstract][Full Text] [Related]
33. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. Köhne CH; Schöffski P; Wilke H; Käufer C; Andreesen R; Ohl U; Klaasen U; Westerhausen M; Hiddemann W; Schott G; Harstick A; Bade J; Horster A; Schubert U; Hecker H; Dörken B; Schmoll HJ J Clin Oncol; 1998 Feb; 16(2):418-26. PubMed ID: 9469324 [TBL] [Abstract][Full Text] [Related]
34. Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens. Moehler M; Hoffmann T; Hildner K; Siebler J; Galle PR; Heike M Z Gastroenterol; 2002 Dec; 40(12):957-64. PubMed ID: 12564419 [TBL] [Abstract][Full Text] [Related]
35. Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer. Hartung G; Hofheinz RD; Wein A; Riedel C; Rost A; Fritze D; Kreuser ED; Drees M; Kühnel J; Hehlmann R; Queisser W Onkologie; 2001 Oct; 24(5):457-62. PubMed ID: 11694772 [TBL] [Abstract][Full Text] [Related]
36. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. Köhne CH; Wils J; Lorenz M; Schöffski P; Voigtmann R; Bokemeyer C; Lutz M; Kleeberg C; Ridwelski K; Souchon R; El-Serafi M; Weiss U; Burkhard O; Rückle H; Lichnitser M; Langenbuch T; Scheithauer W; Baron B; Couvreur ML; Schmoll HJ; J Clin Oncol; 2003 Oct; 21(20):3721-8. PubMed ID: 12963704 [TBL] [Abstract][Full Text] [Related]
37. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study. Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D J Clin Oncol; 1997 Mar; 15(3):908-14. PubMed ID: 9060527 [TBL] [Abstract][Full Text] [Related]
38. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group. J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120 [TBL] [Abstract][Full Text] [Related]
39. A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients. Zori Comba A; Blajman C; Richardet E; Bella S; Vilanova M; Cóppola F; Van Kooten M; Rodger J; Giglio R; Balbiani L; Perazzo F; Montiel M; Chacón M; Pujol F; Mickiewicz E; Cazap E; Recondo G; Lastiri F; Simon J; Wasserman E; Schmilovich A Eur J Cancer; 2001 May; 37(8):1006-13. PubMed ID: 11334726 [TBL] [Abstract][Full Text] [Related]
40. A randomized clinical trial with a weekly regimen of 5-fluorouracil with or without folinic acid in advanced gastrointestinal adenocarcinomas: a preliminary report. Martoni A; Cricca A; Guaraldi M; Farris A; Pannuti F J Chemother; 1989 Jun; 1(3):197-202. PubMed ID: 2677260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]